Naphthalene monoimide derivative ameliorates amyloid burden and cognitive decline in a transgenic mouse model of Alzheimer's disease
Sourav Samanta, Kolla Rajasekhar, Madhu Ramesh, N. Arul Murugan, Shadab Alam, Devanshi Shah, James Premdoss Clement, Thimmaiah Govindaraju
This study identifies TGR63, a naphthalene monoimide derivative, as a promising therapeutic for Alzheimer's disease by reducing amyloid burden and cognitive decline in a mouse model.
Advanced Therapeutics · Jan 28, 2021Peer-reviewedNeuroscience